fashion -WSS

fashion

author：explore 2025-09-02 08:13:48 - browse：16

parts of a dna helix fades while a segment stays solid — Adobe

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age. Those conditions include immune diseases, cancers, neurodegenerative illnesses, and cardiometabolic disorders, such as heart attacks, strokes and diabetes.

With an initial of $50 million from the venture firm Flagship Pioneering, Quotient will be located in Cambridge, Mass., and Cambridge, England. Most of the academic co-founders work in the UK city. Quotient is the first Flagship-backed biotech that will be based in both countries.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： Mike Pence clashes with Tucker Carlson in Iowa

WSS

Grail faces three suits alleging harassment, retaliation

Indictment alleges Trump's ex

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Mike Pence clashes with Tucker Carlson in Iowa

Can CDC director Mandy Cohen drive consensus in Washington?

Why police arrested suspected Gilgo Beach killer away from his house

focus

fashion

entertainment

Drug repurposing or repositioning? The language matters

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Apple is now the first public company to be valued at $3 trillion

Treatments for cramps don't cut it. Why aren't there better options?

Walensky prepares to leave CDC — and Congress — behind

Georgia court denies Trump's request to quash DA's 2020 election probe

What does generative AI mean for health care? We asked experts

Judge sides with young activists in first

Novavax promises a turnaround & Lilly roils the obesity market

Biogen’s boardroom scandal saddles CEO with first crisis

entertainment

Why police arrested suspected Gilgo Beach killer away from his house

Who gets to use the title 'doctor'?

BMS, looking to build heart drug business, turns to AI for diagnosis

Argenx drug significantly slows progression of nerve disorder

Georgia court denies Trump's request to quash DA's 2020 election probe

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Wikipedia

explore

focus

Wikipedia